: Atreca downgraded to neutral from outperform at Wedbush; price target is cut to $1 from $4

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Generated by Feedzy